title: Axitinib dose titration: what's the limiting factor?
authors.affiliation: Medical Oncology Unit, University Hospital, Parma, Italy. Electronic address: sebabuti@libero.it.
authors.forename: Sebastiano
authors.initials: S
authors.lastname: Buti
authors.forename: Camillo
authors.initials: C
authors.lastname: Porta
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage*; D000077784:Axitinib; D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000556:secondary*; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage*; D007191:Indazoles / Q000008:administration & dosage*; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D008297:Male; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage*
chemical_list: D000970:Antineoplastic Agents; D007093:Imidazoles; D007191:Indazoles; D047428:Protein Kinase Inhibitors; D000077784:Axitinib